Pharmacology In Drug: Discovery And Development
The landscape of drug discovery is evolving rapidly, driven by technological breakthroughs that make the pharmacological evaluation of drugs faster, safer, and more precise.
PD helps researchers establish the , which determines the minimum effective concentration of a drug and the threshold where it becomes toxic. Pharmacokinetics (PK): What the Body Does to the Drug
During this phase, (test tube/cell culture) pharmacology dominates. High-throughput screening allows researchers to test millions of compounds against a target. However, finding a "hit" is only the first step. Pharmacologists must then profile these hits for "drug-likeness," using early ADME studies to weed out molecules that are unstable or insoluble. pharmacology in drug discovery and development
[Target Identification] ➔ [Target Validation] ➔ [High-Throughput Screening] ➔ [Lead Optimization] Target Identification and Validation
To understand pharmacology’s role, one must first understand its two fundamental subdivisions. In drug development, these two pillars are the yardsticks by which every potential candidate is measured. The landscape of drug discovery is evolving rapidly,
Pharmacologists use in vitro (cell cultures) and in vivo (animal models) systems to confirm that manipulating this target produces a desired therapeutic effect.
— summarized as "what the body does to the drug" — describes the journey of a drug from the moment it is administered until it is eliminated from the body. This process is typically broken down into four key stages, often referred to as ADME: If you share with third parties
This public link is valid for 7 days and shares a thread, including any personal information you added. This link or copies made by others cannot be deleted. If you share with third parties, their policies apply. Can’t copy the link right now. Try again later.
Testing begins in vitro (using cell cultures or isolated tissues) and progresses to in vivo (using animal models) to evaluate how the drug behaves in a living, complex organism.
The classical view of pharmacology (one drug, one receptor, one disease) is obsolete. Modern pharmacology is tackling complexity.